www.MigraineTreatmentReport.com
https://clinicaltrials.gov/ct2/show/NCT03885154?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Condition : Migraine in Children
Interventions : Drug: Valproic Acid (VPA); Drug: Dihydroergotamine (DHE)
Sponsor : Kimberly S Jones
Recruiting
Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine
NCT03885154
Thu, 21 Mar 2019 12:00:00 EDT
Last Update Posted: 03/21/19 09:51AM
https://clinicaltrials.gov/ct2/show/NCT03874832?type=Intr&cond=Migraine&lupd_s=02%2F28%2F2019&lupd_d=14
Conditions : Migraine With Aura; Migraine Without Aura; Migraine
Intervention : Drug: Dihydroergotamine
Sponsor : Satsuma Pharmaceuticals, Inc.
Completed
A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
NCT03874832
Thu, 14 Mar 2019 12:00:00 EDT
Last Update Posted: 03/14/19 09:43AM
